fbpx
QQQ
+ 1.43
339.81
+ 0.42%
DIA
-2.15
347.27
-0.62%
SPY
-0.76
425.07
-0.18%
TLT
-1.05
143.36
-0.74%
GLD
-1.21
176.95
-0.69%

What's Up With Sellas Life Sciences Stock Today?

May 14, 2021 1:02 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Sellas Life Sciences Group Inc (NASDAQ:SLS) shares are trading higher by 8.3% at $8.24 after the company reported first-quarter EPS results up from last year.

Sellas Life Sciences reported quarterly losses of 16 cents per share, which represents a marked improvement over losses of 66 cents per share from the same period last year.

Sellas Life Sciences is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

Sellas Life Sciences Stock May Have Broken Out Of Pennant Pattern: What's Next?

SELLAS Life Sciences Group Inc. (NASDAQ: SLS) shares rallied Tuesday as retail traders try to push the stock higher. read more